Repair Biotechnologies, Inc.

The Repair Biotechnologies cholesterol degradation platform (CDP) produces therapies that can rapidly reverse atherosclerosis, the age-related buildup of obstructive fatty plaques in blood vessels that is the direct cause of 27% of all human mortality via stroke and heart attack, as well as treating other major age-related and obesity-related conditions.